The cystic fibrosis transmembrane conductance regulator (CFTR) can conduct both Cl– and HCO3– ions although there is a preference for Cl– (Kunzelmann et al. 1991). In rat colon, direct manipulation of intracellular cAMP can stimulate HCO3– secretion through a pathway dependent on CFTR (Cuthbert et al. 1999). Here we have examined the effects of carbachol on HCO3– secretion through CFTR in rat distal colon.
The terminal segment of colon (5 cm) was removed from adult male Wistar rats that had been humanely killed by cervical dislocation. After washing in Krebs solution (mM: NaCl 119, KCl 4.7, NaHCO3 24.8, MgSO4 1.2, KH2PO4 1.2, CaCl2 2.5, glucose 11.1) the smooth muscle was removed and the mucosal sheet mounted in an Ussing chamber (area 0.5 cm2) where apical and basolateral baths contained Krebs solution at 37 °C, gassed with 95 % O2 and 5 % CO2. Ion replacement experiments were performed using low-Cl– Krebs solution prepared by iso-osmotically replacing NaCl with sodium gluconate. In addition, Cl– and HCO3– were replaced using the following solution (mM: sodium gluconate 130, potassium gluconate 5, MgSO4 1.2, calcium gluconate 5.8, Hepes 10, glucose 10, pH 7.4 with NaOH). All values represent the change in ISC (ΔISC) from baseline (mean ± S.E.M.), and Student’s unpaired t test was used for statistical analysis (P < 0.05 was considered significant).
Spontaneous short-circuit current (ISC) was 17.0 ± 2.0 mA cm-2 (n = 60) with a resistance of 105 ± 4 Ω cm-2 and an open circuit transepithelial potential difference of -2.0 ± 0.2 mV. Basolateral carbachol (100 mM, n = 14) stimulated a triphasic response consisting of an initial increase in ISC (phase 1, 12.4 ± 2.0 mA cm-2) followed by a decrease (phase 2, 6.3 ± 2.4 mA cm-2) then a large increase (phase 3, 55.9 ± 8.3 mA cm-2) that slowly decayed to a stable plateau. Apical amiloride (100 mM, n = 19) did not alter the carbachol-stimulated response. Basolaterally applied bumetanide (100 mM, n = 10) significantly attenuated all three phases of the carbachol-stimulated ΔISC (phase 1, 4.6 ± 2.0 mA cm-2, P < 0.02; phase 2, 0.9 ± 0.7 mA cm-2, P < 0.05; phase 3, 7.4 ± 0.9 mA cm-2, P < 0.001). The carbachol-evoked ΔISC was also significantly reduced compared with control, but not abolished, in low-Cl– Krebs solution (P < 0.02 for all three phases, n = 10). In Cl–– and HCO3–-free conditions, however, the carbachol-evoked ΔISC was abolished (n = 3). In low-Cl– conditions where there is still a residual HCO3– secretion in response to carbachol, DPC (100 mM apically and basolaterally, n = 6) was found to significantly reduce phases 1 and 3 of the ΔISC (phase 1, 0.5 ± 0.1 mA cm-2, P < 0.01; phase 3, 5.0 ± 3.2 mA cm-2, P < 0.05).
These results suggest that carbachol-stimulated ΔISC is due to both Cl– and HCO3– secretion, although Cl– secretion is predominant, similar to results in porcine bronchial epithelia with acetylcholine (Trout et al. 1998). Blocking the Cl– component of ΔISC, using bumetanide or low-Cl–, reveals the HCO3– current, which can be significantly attenuated by the CFTR channel blocker DPC, suggesting that HCO3– is carried through CFTR in rat distal colon.
M.B. is supported by a Glasgow Caledonian University Research Studentship.
All procedures accord with current UK legislation.